Antibody Characterization Report for SCARB2 (UniProt ID: Q14108) for use in western blot, immunoprecipitation, and immunofluorescence
Authors/Creators
- 1. Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
Description
Here we have characterized twelve SCARB2 commercial antibodies for western blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. This research was partly funded by the G-Can (GBA1-Canada) initiative, an open-science collaboration dedicated to advancing research on Parkinson's disease associated with GBA1 mutations. G-Can is supported by The Hilary & Galen Weston Foundation, Silverstein Foundation, and J. Sebastian van Berkom and Ghislaine Saucier. This work was also supported by a grant from the Quebec Consortium for Drug Discovery (CQDM), a grant from the Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec.
Files
SCARB2_YCharOS report - v2.pdf
Files
(1.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:0f284423f91c2741f9417356ce16b2d3
|
1.3 MB | Preview Download |